Design: Secondary analysis of data from the randomized, placebo-controlled Heart Outcomes Prevention Evaluation 2 (HOPE-2) trial.
设计——次级数据分析来自于随机安慰剂对照心脏预防评估2试验。
In the Progress trial, perindopril and indapamide was shown to be useful also for secondary prevention of stroke. This is another risk group.
在Progress试验中，培多普利和吲哒帕胺显示对中风的2级预防有效，这是另一个危险人群。
应用推荐